lorista h 50 mg/12,5 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - losartanum kalicum, hydrochlorothiazidum - apvalkotā tablete - 50 mg/12,5 mg
lorista h 100 mg/12,5 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - losartanum kalicum, hydrochlorothiazidum - apvalkotā tablete - 100 mg/12,5 mg
ringer fresenius šķīdums infūzijām
fresenius kabi polska sp.z o.o., poland - kalcija chloridum, kalii chloridum, natrii chloridum - Šķīdums infūzijām
risedronate sodium actavis 35 mg apvalkotās tabletes
actavis group ptc ehf., iceland - nātrija rizedronāts - apvalkotās tabletes - 35 mg
qutavina
eurogenerics holdings b.v. - teriparatide - osteoporoze - kalcija homeostāze - qutavina is indicated in adults. osteoporozes ārstēšana sievietēm pēc menopauzes un vīriešiem ar paaugstinātu lūzuma risku. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. attieksmi pret osteoporozi saistīts ar ilgstošu sistēmisku glikokortikoīdu terapiju sievietēm, gan vīriešiem, paaugstināts lūzums.
livogiva
theramex ireland limited - teriparatide - osteoporoze - kalcija homeostāze - livogiva is indicated in adults. osteoporozes ārstēšana sievietēm pēc menopauzes un vīriešiem ar paaugstinātu lūzuma risku. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. attieksmi pret osteoporozi saistīts ar ilgstošu sistēmisku glikokortikoīdu terapiju sievietēm, gan vīriešiem, paaugstināts lūzums.
sondelbay
accord healthcare s.l.u. - teriparatide - osteoporoze - kalcija homeostāze - sondelbay is indicated in adults. osteoporozes ārstēšana sievietēm pēc menopauzes un vīriešiem ar paaugstinātu lūzuma risku. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. attieksmi pret osteoporozi saistīts ar ilgstošu sistēmisku glikokortikoīdu terapiju sievietēm, gan vīriešiem, paaugstināts lūzums.
teriparatide sun
sun pharmaceutical industries europe b.v. - teriparatide - osteoporosis; osteoporosis, postmenopausal - kalcija homeostāze - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
kauliv
strides pharma (cyprus) limited - teriparatide - osteoporosis; osteoporosis, postmenopausal - kalcija homeostāze - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
edistride
astrazeneca ab - dapagliflozin propāndiols monohidrāts - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - cukura diabēts - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. papildus citām zālēm, lai ārstētu 2. tipa cukura diabētu. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 un 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.